SWI Initiates Coverage - LiveWire Ergogenics,Inc.  (OTC: LVVV)
SWI Initiates Coverage on LiveWire Ergogenics, Inc. 
Early Development Stage Early Investment Opportunity

Los Angeles, CA, August 16, 2017 - SWI announced today that it has initiated coverage on LiveWire Ergogenics, Inc (OTC: LVVV).  As a principle, we typically do not cover companies in such an early development stage with a sub-penny share price. After conducting initial research and establishing direct communication with the CEO and management team of LiveWire, we decided it was justified to make an exception and initialize early analyst coverage for the Company now. As any stock at this early stage of development, LiveWire represents a high risk - potentially high reward ratio. We encourage our subscribers to not rely on our report only, but to also conduct their own research and consult with their personal investment advisors before investing.

Bill Hodson, CEO of LiveWire Ergogenics, Inc. (OTC PINK: LVVV), has rejuvenated its management team, has added an experienced COO and entered into crucial new strategic alliances and development agreements. The Company is in the process of establishing two reputable research teams to address two underserved sectors of the cannabis industry. Developing products in highly specialized market sectors of the industry, supported by structured research and the potentially resulting commercial products will, be the main focus of the Company’s strategy moving forward.

LiveWire Ergogenics, Inc. (LVVV) is focused on identifying and monetizing current and future trends in the health and wellness industry, derived from, or enhanced with legal cannabis products. The Company is focused on establishing and advancing research partnerships for specific ailments with high "sufferer" populations, cloning of high-quality and organic cannabis strains, to effectively address these ailments, dosing verification of zero pesticide products for quality brands and the general development and commercialization of cannabinoid based products and services. The team at LiveWire Ergogenics is committed to developing legal, high-quality and organically clean products and generating innovative ideas for the advancement of the company, its customers, and the entire industry
1600 North Kraemer Blvd.
Anaheim, CA 92806
If you want to follow all other companies that we cover with more in depth research reports, go to our research site at www.swiresearch.com/report-index to download the reports,
or visit
www.stockwatchindex.com for up to date news on the covered companies.
Please feel free to
re-distribute the reports to your friends and colleagues.
S tockWatchIndex  and SWI Research (SWI) are not registered investment advisers and the information  provided herein or any other SWI publication is not to be construed as personal financial advice, or a solicitation to buy or sell stock. SWI makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in its publications or on its web sites. Some of the published information has been provided by the companies covered, generated by publicly available sources, or what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or warrant any results from use of the information. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in this publication, any other SWI publication, or its web sites and is not obligated to update and/or correct information. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. SWI expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided.  SWI has been compensated with twenty five million restricted shares (subject to the restrictions of rule 144)  by the Company  for the dissemination of this and future releases and  for continuing consulting and advisory services The included information is subject to change without notice. Please visit  www.swiresearch.com/#!legal-ease/lmvw1   for a full text of our Disclaimer, Privacy policy and Terms of Use.